Old Teams May Have New Homes as Franchises Seek More Modern, Profitable Venues

Gilead Sciences Inc., a drug research company, said Monday it plans to buy Myogen Inc. for about $2.5 billion in cash, giving Gilead access to Myogen's heart-drug candidates.

Sales at Wal-Mart Rise 1.8% Los Angeles Times - Wal-Mart Stores Inc. said September's same-store sales in the US rose about 1.8%, the smallest gain since June, when sales increased 1.2%.